Search Results

Fauna Bio announced today a preprint in BioRxiv that senior scientist Ryan J. Sprenger contributed during his PhD. and postdoctoral work which highlights the intricate mechanisms governing skeletal muscle metabolism during animal hibernation.

Fauna Bio announced today Dr. Lara Do Amaral-Silva, assistant professor of biology at Wake Forest University, as the recipient of the FaunaBio Translational Research Award through the American Physiological Society (APS).

Fauna Bio, a biotechnology company that leverages animal genomics to improve human health, announces Senior Research Physiologist Ryan Sprenger, Ph.D., has been awarded a NASA Innovative Advanced Concepts grant.

Fauna Bio today announced a multi-year agreement with Eli Lilly and Company to apply Fauna’s Convergence™ artificial intelligence (AI) platform to support preclinical drug discovery efforts in obesity.

Eli Lilly has signed a multi-year contract with animal genomics biotech Fauna Bio to use its artificial intelligence platform to discover drug targets for obesity in a deal worth nearly half a billion dollars.

Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.

Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is the first of its kind to visualize the intersection between animal gene expression data and human diseases in one comprehensive map.